The estimated Net Worth of Thomas P Rice is at least $4.17 Milión dollars as of 17 June 2021. Mr. Rice owns over 841 units of Chemed stock worth over $2,942,737 and over the last 15 years he sold CHE stock worth over $1,044,277. In addition, he makes $182,744 as Independent Director at Chemed.
Thomas has made over 2 trades of the Chemed stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 841 units of CHE stock worth $388,937 on 17 June 2021.
The largest trade he's ever made was selling 2,000 units of Chemed stock on 27 February 2019 worth over $655,340. On average, Thomas trades about 158 units every 47 days since 2010. As of 17 June 2021 he still owns at least 5,188 units of Chemed stock.
You can see the complete history of Mr. Rice stock trades at the bottom of the page.
Thomas Patrick Rice Jr. serves as Independent Director of the Company. Mr. Rice’s experience, qualifications, attributes and skills include having served as Chief Executive Officer of Andrx Corporation, Fort Lauderdale, Florida (specialty pharmaceuticals) (“Andrx”), from February 2004 to November 2006, when Andrx was sold to Watson Pharmaceuticals. Following the sale, Mr. Rice returned as General Manager and Majority Partner of Columbia Investments LLC, Baltimore, Maryland, which invests in local emerging businesses in Baltimore and which Mr. Rice co-founded in January 1996. He was also a Director of Par Pharmaceuticals, Woodcliff Lake, New Jersey (drug development, manufacture, and marketing) until November 2012. From January 1999 to March 2003, he was President and Chief Executive Officer of Chesapeake Biological Laboratories, Inc., Solomons, Maryland (pharmaceuticals manufacturing) (“Chesapeake”). Before co-founding Columbia Investments LLC, Mr. Rice served as Executive Vice President and Chief Operating Officer of Circa Pharmaceuticals, Inc., Copiague, New York (pharmaceuticals manufacturing) (“Circa”), from June 1993 to January 1996. Mr. Rice was also the Chief Financial Officer of Circa from June 1993 to January 1995. Prior to joining Circa, Mr. Rice spent seven years as an accountant with Deloitte & Touche LLP, an international accounting firm. He earned a Master’s degree in finance from Loyola University. He was a director of Circa from June 1993 to January 1996, a director of Chesapeake from January 1997 to January 1999 and a director of Andrx from April 2003 to November 2006.
As the Independent Director of Chemed, the total compensation of Thomas Rice at Chemed is $182,744. There are 11 executives at Chemed getting paid more, with Kevin McNamara having the highest compensation of $10,019,800.
Thomas Rice is 70, he's been the Independent Director of Chemed since 2009. There are 6 older and 12 younger executives at Chemed. The oldest executive at Chemed Corp. is Walter Krebs, 86, who is the Independent Director.
Thomas's mailing address filed with the SEC is 2600 CHEMED CENTER, 255 EAST FIFTH STREET, CINCINNATI, OH, 45202.
Over the last 22 years, insiders at Chemed have traded over $138,634,486 worth of Chemed stock and bought 2,293 units worth $478,104 . The most active insiders traders include Kevin J Mcnamara, David Patrick Williams a Spencer S Lee. On average, Chemed executives and independent directors trade stock every 19 days with the average trade being worth of $4,438,497. The most recent stock trade was executed by Nicholas Michael Westfall on 9 September 2024, trading 1,713 units of CHE stock currently worth $975,297.
chemed is a holding company. our wholly owned subsidiaries are vitas and roto-rooter services company. vitas is a healthcare company that specializes in hospice or end of life care for the terminally ill. roto-rooter is the nation's largest provider of plumbing and drain care services.
Chemed executives and other stock owners filed with the SEC include: